Fiore S.

Impact of serological and PCR testing requirements on the selection of COVID-19 convalescent plasma donors

Article

Abstract: Background: Convalescent plasma is undergoing randomized trials as a potential therapeutic option fo

Palabras claves:

blood component preparations, donors, immunology (other than RBC serology)

Autores:

Ahmed T., Anderson A., Andrew M., Arata J., Baumeister M., Bennett-Guerrero E., Boudreau S., Brand M., Brill P., Browne N.J., Bryan A., Caravella G.A., Carter J.A., Cosgrove M.E., Daley N., David Edward Komatsu, Festa L., Fiore S., Freedenberg A.T., Fries B.C., Gearwar C., Generale L.M., Grewal S., Halper D., Harbourne S., Harper L., Hecker-Crawford A., Kaell D., Keister M., Lamb J., Lavorna A., Lee D., Letscher C., Madigan D., Mamone L.J., Markarian-Askinazi K., Mavarez-Martinez A., McKenna C., Munoz S., Nachman S., O'Keefe J., Pallai A., Pol C., Propper G., Rago M.G., Repetti R., Roemer E., Roggemann C., Romeiser J.L., Sahib H., Salman H., Scherl W., Senzel L., Shevik M.E., Singh S., Sisti A., Skinner S., Smith-McAllister L., Spitzer E., Stein R., Talbot L.R., Vacchi-Suzzi C., Vivas K., Wong A.

Fuentes:

scopus